Diflomotecan. Ipsen.
Osheroff
Neil
N
Vanderbilt University School of Medicine, Department of Biochemistry, 654 Robinson Research Building, Nashville, TN 37232-0146, USA. osheron@ctrvax.vanderbilt.edu
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004264:DNA Topoisomerases, Type I / Q000378:metabolism; D015507:Drugs, Investigational / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology; D059004:Topoisomerase I Inhibitors
D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; D004264:DNA Topoisomerases, Type I; C424962:diflomotecan; D002166:Camptothecin